Large U.S. Buyers Turn to Eevia Amid Tariff Driven Supply Chain Uncertainty

Eevia Health Plc is experiencing a sharp spike in requests for prices and products as ripple effects from the U.S. imposed China tariffs, which now disrupt global nutraceutical supply chains. Several major U.S.-based companies are urgently seeking alternative sources for compendial plant-based ingredients—especially low-concentrate powders—to mitigate the risk of stockouts and margin pressure caused by […]

Read more...

Launching a New Health Ingredient

We are proud to announce our participation at Vitafoods 2025, the leading global nutraceutical trade show, taking place in Barcelona, Spain, 20–22 May 2025. During the event, Eevia will launch a new, innovative health ingredient and support the re-launch of a third ingredient in collaboration with a new partner. Vitafoods is the premier meeting place […]

Read more...

Groundbreaking Bioequivalence Benchmarking between Fenoprolic® and Pycnogenol®

Eevia Health has published a whitepaper summing a study that compares the bioequivalence between Fenoprolic® and Pycnogenol®, two leading pine bark extracts known for their high levels of oligomeric proanthocyanidins (OPCs). Fenoprolic® is derived from the bark of Arctic pine trees (Pinus sylvestris) sourced from the pristine forests of Finnish Lapland. This region’s pure environment ensures the highest quality raw materials, resulting in a potent […]

Read more...

Eevia Publishes a New Research Article Comparing Fenoprolic® and Pycnogenol®

Eevia publishes an article on the comparison of bioactivity profiles between Fenoprolic®, Eevia’s pine bark extract, and Pycnogenol®. Eevia extensively studied the bioactivity of Fenoprolic® and Pycnogenol® with the Eurofins BioMAP® Human Primary Cell Phenotypic profiling platform. The article benchmarks Eevia’s extract against the market leader for OPC extracts from pine bark. The study showed […]

Read more...

Erik Eide to the new position of Commercial Director

To advance the commercial development of Eevia Health, we are thrilled to announce that Erik Eide has joined our team as Commercial Director. It is a new position that will be key to future revenue generation. Erik’s focus is on developing Eevia Health’s position as a trusted supplier of nutraceutical ingredients. He complements the leadership […]

Read more...



Meet Eevia team at SSW

Meet Eevia team at SSW Polyphenols will play a huge role in supporting human health. Eevia Health extracts some of the most potent polyphenols on this planet from arctic organic plant material. If you are interested in discussing the intriguing prospects of powerful polyphenols, let us meet at Supply Side West at booth # 3541. […]

Read more...

Unlocking the Bioactive Potential of Elderberry Extract

Unlocking the Bioactive Potential of Elderberry Extract: A Comprehensive BioMAP Analysis and Comparative Bioactivity Profiling of FENO-SAMBUCUS™ Eevia Health continue our scientific efforts to elucidate the way our botanical extracts work in the human body and possible clinical benefits they offer. For this purpose, we have completed a large comparative study of 11 different compounds […]

Read more...

Feno-Myrtillus 36 Organic – The Sustainable Choice

Feno-Myrtillus 36 Organic – The Sustainable Choice Arctic Bilberry extracts with a standardized content of anthocyanins provide many essential health benefits for humans. Eevia Health, the only Arctic manufacturer of organic bilberry extract, is providing the first of two white papers on the leading bilberry extract on the market. The second white paper, to be […]

Read more...